We are live on ! Find out more
ARRY

Array Biopharma Inc
ARRY

Delisted

ARRY was delisted on the 29th of July, 2019.

Back to rankings

128 hedge funds and large institutions have $447M invested in Array Biopharma Inc in 2013 Q2 according to their latest regulatory filings, with 128 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

51% less call options, than puts

Call options by funds: $396K | Put options by funds: $809K

Holders
128
Holders Change
+128
Holders Change %
–
% of All Funds
4.18%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.13%
New
128
Increased
–
Reduced
–
Closed
–
Calls
$396K
Puts
$809K
Net Calls
-$413K
Net Calls Change
-$413K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BI
1
BVF Inc
California
$50.5M +$59.9M +11,131,858 New
DM
2
Deerfield Management
New York
$49.4M +$58.5M +10,885,406 New
T. Rowe Price Associates
3
T. Rowe Price Associates
Maryland
$29.7M +$35.2M +6,546,700 New
O
4
OrbiMed
New York
$22.1M +$26.2M +4,865,000 New
RG
5
Redmile Group
California
$21.7M +$25.7M +4,769,368 New
Fidelity Investments
6
Fidelity Investments
Massachusetts
$21.6M +$25.6M +4,768,770 New
BIT
7
BlackRock Institutional Trust
California
$20.5M +$24.3M +4,521,442 New
State Street
8
State Street
Massachusetts
$18.4M +$21.8M +4,054,339 New
BFA
9
BlackRock Fund Advisors
California
$18.1M +$21.5M +3,993,580 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$17.3M +$20.5M +3,807,191 New
KIA
11
Kopp Investment Advisors
Minnesota
$16.3M +$19.3M +3,587,128 New
QF
12
QVT Financial
New York
$15.6M +$18.5M +3,437,293 New
AG
13
Artal Group
Luxembourg
$13.6M +$16.1M +3,000,000 New
GC
14
GMT Capital
Georgia
$10.5M +$12.4M +2,311,691 New
AC
15
Apex Capital
California
$8.44M +$9.99M +1,857,900 New
Northern Trust
16
Northern Trust
Illinois
$7.41M +$8.78M +1,632,051 New
BBA
17
Baker Bros. Advisors
New York
$6.81M +$8.07M +1,500,000 New
Principal Financial Group
18
Principal Financial Group
Iowa
$6.37M +$7.55M +1,403,004 New
Deutsche Bank
19
Deutsche Bank
Germany
$6.12M +$7.25M +1,347,871 New
TA
20
Teachers Advisors
New York
$4.59M +$5.43M +1,010,116 New
PI
21
Putnam Investments
Massachusetts
$4.09M +$4.85M +901,846 New
CIP
22
Chartwell Investment Partners
Pennsylvania
$3.54M +$4.19M +778,655 New
TC
23
TFS Capital
Pennsylvania
$3.41M +$4.04M +750,360 New
PCP
24
Perimeter Capital Partners
Georgia
$2.91M +$3.45M +641,277 New
Bank of New York Mellon
25
Bank of New York Mellon
New York
$2.68M +$3.17M +589,784 New
1
2 3 4 5

ARRY Hedge Fund Activity: Q2 2013 in Review

128 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Array Biopharma Inc (ARRY) for Q2 2013, worth a combined $447M.

Buyers outnumbered sellers: 128 funds opened new ARRY positions and 0 closed out — a net gain of 128 holders — while 0 added to existing stakes and 0 trimmed.

  • 128 institutional investors held Array Biopharma Inc (ARRY) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $447M of Array Biopharma Inc stock for Q2 2013.
  • 128 funds opened new Array Biopharma Inc positions in Q2 2013 and 0 closed out, a net change of +128 holders.

Based on aggregated 13F filings for Q2 2013.